Medusa Therapeutics Limited
PrivateCompany Overview
Medusa Therapeutics Limited operates in Healthcare & Life Sciences and is based in Hong Kong. It was founded in 2021.
Medusa Therapeutics Limited is a biotechnology company that develops drug discovery technology and small molecule drugs targeting liquid-liquid phase separated biomolecular condensates.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medusa Therapeutics Limited Comparables
Compare Medusa Therapeutics Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nereid Therapeutics | 89% | |
| Dewpoint Therapeutics | 85% | |
| ETERN Therapeutics | 84% |
For institutional investors. Book with your work email.
Medusa Therapeutics Limited Funding Rounds
Historical fundraising activity
Medusa Therapeutics Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medusa Therapeutics Limited's valuation, stock price, and market status.
Is Medusa Therapeutics Limited a public or private company?
Medusa Therapeutics Limited is a private company.
What is the current stock price of Medusa Therapeutics Limited?
Medusa Therapeutics Limited is a private company, so its shares have no public market price. Caplight tracks Medusa Therapeutics Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medusa Therapeutics Limited worth (valuation)?
Valuation information for Medusa Therapeutics Limited is not publicly available.
Can I buy Medusa Therapeutics Limited stock?
Medusa Therapeutics Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medusa Therapeutics Limited's last funding round?
Funding round information for Medusa Therapeutics Limited is not publicly available.
Who are the main investors in Medusa Therapeutics Limited?
Investor information for Medusa Therapeutics Limited is not publicly disclosed.
Will Medusa Therapeutics Limited IPO soon?
No public IPO plans have been announced for Medusa Therapeutics Limited.
How can I track Medusa Therapeutics Limited secondary market activity?
Caplight tracks bids, offers, and trades in Medusa Therapeutics Limited's shares on secondary markets.